rosiglitazone has been researched along with Injuries, Spinal Cord in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Cui, L; Cui, S; Feng, Z; Gao, Q; Hu, L; Li, Q; Li, S; Meng, Q; Zhang, H; Zhang, X | 1 |
Li, H; Wang, L; Yang, X; Zhang, Q | 1 |
Du, J; Li, X; Lin, X; Ling, Z; Xu, S | 1 |
Sullivan, PG; Yonutas, HM | 1 |
Hu, W; Meng, B; Tang, T; Zhang, Q | 1 |
Huang, C; Shi, Q; Tang, T; Yang, H; Zhang, Q | 1 |
Huang, C; Meng, B; Tang, T; Yang, HL; Zhang, HT; Zhang, Q | 1 |
Liang, XJ; Meng, QQ; Shen, HY; Wang, P; Wang, XP; Wu, YF; Yang, JW | 1 |
1 review(s) available for rosiglitazone and Injuries, Spinal Cord
Article | Year |
---|---|
Targeting PPAR isoforms following CNS injury.
Topics: Animals; Brain Injuries; Drug Design; Humans; Mitochondrial Proteins; Molecular Targeted Therapy; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Protein Isoforms; Rosiglitazone; Spinal Cord Injuries; Thiazolidinediones | 2013 |
7 other study(ies) available for rosiglitazone and Injuries, Spinal Cord
Article | Year |
---|---|
Rosiglitazone Ameliorates Spinal Cord Injury
Topics: Animals; Disease Models, Animal; Humans; Hypoglycemic Agents; Inflammation; Male; Mitophagy; Neural Stem Cells; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord Injuries | 2022 |
PPAR-γ agonist rosiglitazone reduces autophagy and promotes functional recovery in experimental traumaticspinal cord injury.
Topics: Animals; Autophagy; Dose-Response Relationship, Drug; Female; Nerve Regeneration; PPAR gamma; Rats; Rats, Sprague-Dawley; Recovery of Function; Rosiglitazone; Spinal Cord Injuries; Thiazolidinediones; Treatment Outcome | 2017 |
Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces secondary damage in experimental spinal cord injury.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Interleukin-1beta; Male; Motor Activity; Peroxidase; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord; Spinal Cord Injuries; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2013 |
PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Neuroprotective Agents; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord Injuries; Thiazolidinediones; Time Factors | 2010 |
Comparative neuroprotective effects of methylprednisolone and rosiglitazone, a peroxisome proliferator-activated receptor-γ following spinal cord injury.
Topics: Analysis of Variance; Animals; bcl-2-Associated X Protein; Disease Models, Animal; Gene Expression Regulation; HSP72 Heat-Shock Proteins; In Situ Nick-End Labeling; Interleukin-1beta; Male; Methylprednisolone; Motor Activity; Neuroprotective Agents; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord Injuries; Thiazolidinediones; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Effects of a single dose of methylprednisolone versus three doses of rosiglitazone on nerve growth factor levels after spinal cord injury.
Topics: Animals; Base Sequence; Blotting, Western; Brain-Derived Neurotrophic Factor; DNA Primers; Drug Administration Schedule; Laminectomy; Locomotion; Methylprednisolone; Nerve Growth Factor; PPAR gamma; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Spinal Cord Injuries; Thiazolidinediones | 2011 |
Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury.
Topics: Animals; Anti-Inflammatory Agents; Antigens, Nuclear; Antimetabolites; Blood-Brain Barrier; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Female; Flow Cytometry; Inflammation; Intermediate Filament Proteins; Movement; Nerve Tissue Proteins; Nestin; Neural Stem Cells; NF-kappa B; PPAR gamma; Rats; Rats, Sprague-Dawley; Recovery of Function; Rosiglitazone; Spinal Cord Injuries; Thiazolidinediones | 2011 |